Senior Director/Executive Director, Manufacturing Sciences and Technology, Holly Springs
Genentech | |
remote work
| |
United States, North Carolina, Holly Springs | |
Feb 05, 2026 | |
|
The Position
Welcome to Holly Springs, North Carolina- home to Roche/Genentech's largest-ever investment: a $2B greenfield start-up where next-generation technology, high-performing teams and Operational Excellence converge to create the global standard for high-volume, highly-efficient Drug Product manufacturing. The facility's core is defined by Innovation - leveraging advanced automation, robotics, digital tools, real-time data analytics, and simple, streamlined processes to produce the highest quality medicines. This plant meets today's demand for CVRM (Cardiovascular, Renal, and Metabolism) medicines and is scalable to grow with the portfolio, which focuses on next-generation metabolic medicines specifically targeting the global obesity epidemic and Type 2 diabetes. This is a fast-paced, entrepreneurial environment with a high-level of accountability, with planned launch in 2028. Are you a problem-solver and change-agent who thrives in a Team environment, eager to tackle the most complex manufacturing challenges? If so, this is a once-in-a-lifetime opportunity to launch a state-of-the-art facility from the ground-up and shape the culture of our organization for the next generation. Join us in Holly Springs, where you won't just build a plant-you will build the future of medicine. The Opportunity: As a member of the Holly Springs Site Leadership Team (SLT), you will be accountable for the Product Lifecycle (Technical Risk Assessment, Product Control Strategies, Continued Process Verification, Process Robustness Assessment) to include the Process Engineering program and Process Validation program, New Product Introductions (NPIs), Technical Transfers and new technology introduction of this facility through plant start-up in 2028 and ongoing commercial manufacturing. In the start-up and development phase of the project you will work closely with Global Product Development teams as the molecules go through clinical development and operational readiness, taking site ownership for the entire lifecycle of the medicines. You will lead, inspire and influence a highly proficient and engaged team of engineers, scientists and manufacturing experts in technical fit assessments, product introductions, process design and development, and qualification and validation activities through licensure. The team is also responsible for the internal or external product transfers to commercial operations. This includes strategic long-range planning and operational planning. Together with the SLT, you will be accountable for setting a high performance site culture.
Who you are:
While initially you will perform a mix of remote work we will transition to fully onsite work by mid-2026. The expected salary range for this position based on the primary location for this position of Holly Springs is $173,950 - $323,050 (Senior Director level) or $204,400 - $379,600 (Executive Director level). Actual pay will be determined based on experience, level, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below. Link to Benefits Relocation benefits are provided Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. | |
remote work
Feb 05, 2026